Statute
Ryan Haight Act
27 published works
Healthcare Law Blog
2026 Extension of Telemedicine Prescribing Flexibilities: Impacts on Patients and Providers
By Hoyt Sze, Tina Watson, Madeline Cunnion
On December 31, 2025, the Drug Enforcement Administration (“DEA”) and the Department of Health and Human Services (“HHS”) jointly issued a Fourth Temporary Rule again extending the telemedicine flexibilities of…
Healthcare Law Insights
DEA’s Pending Telemedicine Rule: What Ketamine Clinics Need to Know
The legal and regulatory landscape for ketamine clinics is shifting once again, as the Drug Enforcement Administration (DEA) prepares to release its “Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for…
Health Law Blog
Telehealth Update: Controlled Substances & E/M Claims
Prior to the COVID-19 public health emergency (“PHE”), the federal Ryan Haight Act allowed a provider to prescribe controlled substance medications to a patient only after conducting an in-person evaluation…
Healthcare Law Blog
Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule
This month, the Drug Enforcement Administration (“DEA”), in conjunction with the Substance Abuse and Mental Health Services Administration (“SAMHSA”), issued a Second Temporary Rule further extending the telemedicine waivers of the…
Health Law Blog
DEA Reverses Course and Extends Telehealth Prescriptions of Controlled Substances
Reversing previously proposed rules, the DEA recently issued new guidance allowing the continued use of telehealth when prescribing controlled substances following the end of the Covid-19 public health emergency (“PHE”).…
Health Law Blog
DEA Reverses Proposed Rule to Extend Telehealth Prescriptions of Controlled Substances
Reversing previously proposed rules, the DEA recently issued new guidance allowing the continued use of telehealth when prescribing controlled substances following the end of the Covid-19 public health emergency (“PHE”).…
Healthcare Law Blog
DEA and SAMHSA Extend Tele-Prescribing Flexibilities
This week, the Drug Enforcement Administration (“DEA”), in conjunction with the Substance Abuse and Mental Health Services Administration (“SAMHSA”), issued a temporary rule extending the telemedicine waivers of the Ryan…
Life Sciences Perspectives
DEA Announces Temporary Extension of COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications
By Roger Cohen|Simone Otenaike
The Controlled Substances Act, as amended by the Ryan Haight Act, generally prohibits prescribing controlled substances via telehealth without a prior in-person examination, subject to certain very limited exceptions. Those…
Health Care Law Matters
Telehealth Practitioners Must Be Aware of the DEA’s Proposed New Rules for Prescribing Controlled Substances via Telemedicine
By Aaron Black
Telehealth practitioners must take note of the DEA’s proposed rule making that would impact the way telehealth practitioners can prescribe controlled substances. The Ryan Haight Act and the Proposed Rules…
Healthcare Law Blog
DEA Proposes Rule for Post-PHE Telemedicine
This blog is the third installment of our Digital Health Trends Series, see previous blog posts here and here. On February 24, 2023, the Drug Enforcement Agency (“DEA”) announced a…